InvestorsHub Logo
Followers 58
Posts 10055
Boards Moderated 1
Alias Born 09/21/2016

Re: georgejjl post# 363776

Sunday, 06/19/2022 9:05:09 AM

Sunday, June 19, 2022 9:05:09 AM

Post# of 458812
Excellent catch & Post Georgejji...

Wednesday 22 June 2022, Christopher Missling
Company: Anavex Life Sciences

Job title: President & Chief Executive Officer

Seminars:
Characterizing Rare Disease Biology in Clinical Studies to Observe Drug Effects in Patient Sub-Populations 11:00 am

Understanding the relevance of Whole Exome Sequencing (WES) and mRNA-seq analyses Using unsupervised computerized AI analysis to assess large data Correlating genomic analysis with extensive clinical data outcomes and endpoint scales

Details:

Understanding the relevance of Whole Exome Sequencing (WES) and mRNA-seq analyses

Using unsupervised computerized AI analysis to assess large data

Correlating genomic analysis with extensive clinical data outcomes and endpoint scales

Day: Day One

https://rare-genetic-neurodegenerative-development.com/speaker/christopher-missling-2/

Good luck and GOD bless,



I am going to suggest a simplified version-TITLE for the Dr.M. talk on June 22...
My suggested TITLE IS:


"THIS IS A FOOTBALLL."...Now, I will SPLAIN how it changes the BP-WS game.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News